Silvia Isabel Rech Franke

Silvia Isabel Rech Franke

Auto-generated profile, based on publicly available information

Silvia Isabel Rech Franke

Universidade de Santa Cruz do Sul, Santa Cruz do Sul, RS, Brasil

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2016 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
SFSilvia I.R. Franke
Silvia I.R. Franke
DBDiana L. Bordin
Diana L. Bordin
DPDaniel Prá
Daniel Prá
JHJoão A.P. Henriques
João A.P. Henriques
Parkinson's disease is characterized by the death of dopaminergic neurons, mainly in the substantia nigra, and causes serious locomotor dysfunctions. It is likely that the oxidative damage to cellular biomolecules is among the leading causes of neurodegeneration that occurs in the disease. Selenium is an essential mineral for proper functioning of the brain, and mainly due to its antioxidant activity, it is possible to exert a special role in the prevention and in the nutritional management of Parkinson's disease. Currently, few researchers have investigated the effects of selenium on Parkinson´s disease. However, it is known that very high or very low body levels of selenium can (possibly) contribute to the pathogenesis of Parkinson's disease, because this imbalance results in increased levels of oxidative stress. Therefore, the aim of this work is to review and discuss studies that have addressed these topics and to finally associate the information obtained from them so that these data and associations serve as input to new research.

1 November 2004 in Food Chemistry
Verified
Journal Article
Closed access
SFS.I.R Franke
S.I.R Franke
Karina CklessKarina Ckless
Karina Ckless
JSJ.D Silveira
J.D Silveira
Gabriel RübensamGabriel Rübensam
Gabriel Rübensam
MBM Brendel
M Brendel
JHJ.A.P Henriques
J.A.P Henriques

10 October 2007 in BioMetals
Verified
Journal Article
Closed access
PDF file
DPDaniel Prá
Daniel Prá
SFSilvia Isabel Rech Franke
Silvia Isabel Rech Franke
RGRaquel Giulian
Raquel Giulian
MYMaria Lúcia Yoneama
Maria Lúcia Yoneama
JDJohnny Ferraz Dias
Johnny Ferraz Dias
JHJoão Antonio Pegas Henriques
João Antonio Pegas Henriques

1 May 2012 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
DPDaniel Prá
Daniel Prá
SFSilvia Isabel Rech Franke
Silvia Isabel Rech Franke
JHJoão Antonio Pêgas Henriques
João Antonio Pêgas Henriques
MFMichael Fenech
Michael Fenech

25 June 2009 in Nutrition and Cancer
Verified
Journal Article
Closed access
DPDaniel Prá
Daniel Prá
SFSilvia Isabel Rech Franke
Silvia Isabel Rech Franke
JHJoão Antonio Pêgas Henriques
João Antonio Pêgas Henriques
MFMichael Fenech
Michael Fenech
There is definitive evidence that iron overload induces oxidative stress and DNA damage, which can enhance carcinogenic risk. However, other evidence suggests that iron deficiency and anemia also increase oxidative stress and DNA damage, which might increase carcinogenesis risk, especially in the gastrointestinal (GI) tract. The aim of this review is to provide essential background information for the accurate interpretation of future research on iron deficiency and increased GI cancer risk. Based on clinical, epidemiological, and experimental evidence, we discuss how iron deficiency might contribute to increased cancer risk through the impairment of several iron-dependent metabolic functions that are related to genome protection and maintenance (e.g., immune responses against cancer-initiated cells, metabolism of toxic compounds, and redox regulation of DNA biosynthesis and repair). Some epidemiological studies have indicated increased risk of GI tumors among individuals with low iron intake or low somatic iron stores, and in vivo data from rodent cancer models indicates the early progression of GI tumors during iron deficiency. Given the preliminary but consistent evidence relating iron deficiency to cancer risk and the fact that iron deficiency affects about one third of the world's population, further studies are needed to define the extent to which iron deficiency might increase GI cancer risk.

1 February 2015 in Nutrition
Verified
Journal Article
Closed access
Joel Henrique EllwangerJoel Henrique Ellwanger
Joel Henrique Ellwanger
PMPatrícia Molz
Patrícia Molz
DDDanieli Rosane Dallemole
Danieli Rosane Dallemole
ASAriana Pereira dos Santos
Ariana Pereira dos Santos
TMTalise Ellwanger Müller
Talise Ellwanger Müller
JHJoão Antonio Pêgas Henriques
João Antonio Pêgas Henriques